Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Of Weekly Subcutaneous Bortezomib In Patients With Steroid-Refractory Or -Dependent Chronic Graft Versus Host Disease

NCT01672229 is registered in ClinicalTrials.gov with Mehrdad Abedi, MD as lead sponsor.

NCT NCT01672229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01672229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Of Weekly Subcutaneous Bortezomib In Patients With Steroid-Refractory Or -Dependent Chronic Graft Versus Host Disease
Lead sponsor
Mehrdad Abedi, MD
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2012
Completion date
April 9, 2018
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease